3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
22
Carcinoma, Basal Cell
10
Uterine Cervical Dysplasia
7
Melanoma
7
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Precancerous Conditions
3
Keratosis
3
Glioma
3
Glioblastoma
3
Condylomata Acuminata
3
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Hutchinson's Melanotic Freckle
2
HIV Infections
2
Astrocytoma
2
Warts
1
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sialorrhea
1
Sexually Transmitted Diseases
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Fluorouracil
12
Radiotherapy
8
Cisplatin
8
pembrolizumab
4
Papillomavirus Vaccines
4
Mitomycin
4
Irinotecan
4
Cyclophosphamide
4
Cetuximab
4
Light Coagulation
3
Interleukin-12 Subunit p35
3
Capecitabine
3
fludarabine phosphate
2
fludarabine
2
atezolizumab
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Trastuzumab
2
Surveys and Questionnaires
2
Radiation
2
Quality of Life
2
Paclitaxel
2
Oxaliplatin
2
Erlotinib Hydrochloride
2
Early Intervention, Educational
2
Carboplatin
2
Biopsy
2
toripalimab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anus Neoplasms
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts